首页 | 本学科首页   官方微博 | 高级检索  
     

中麻黄中2个新天然产物
引用本文:范锡玲,曹彦刚,焦新棉,马新毅,郑晓珂,冯卫生. 中麻黄中2个新天然产物[J]. 中草药, 2024, 55(6): 1899-1907
作者姓名:范锡玲  曹彦刚  焦新棉  马新毅  郑晓珂  冯卫生
作者单位:河南中医药大学药学院, 河南郑州 450046;河南省中药开发工程技术研究中心, 河南郑州 450046
基金项目:国家重点研发计划-中医药现代化研究重点专项(2019YFC1708800)
摘    要:目的 研究中麻黄Ephedra intermedia的化学成分。方法 采用Toyopreal HW-40C、Sephadex LH-20、硅胶和半制备高效液相等多种色谱学技术分离得到单体化合物,并根据其理化性质和波谱学数据鉴定其结构,并通过建立C48/80诱导RBL-2H3细胞脱颗粒体外模型,对中麻黄中所得单体化合物进行体外抗哮喘活性筛选。结果 从中麻黄50%丙酮提取物中分离得到21个化合物,分别鉴定为3-羟基-5-(4’-羟基苯基)戊酸乙酯(1)、3-羟基-5-(4’-羟基苯基)戊酸甲酯(2)、儿茶酚(3)、苯甲酸(4)、5-(4-羟基苯基)-2-戊烯酸(5)、(+)-rhododendrol(6)、frambinone(7)、香草乙酮(8)、4-羟基-3-甲氧基苯甲酸甲酯(9)、3,4-二羟基苯乙醇(10)、姜酮(11)、原儿茶酸(12)、3,5-二羟基-4-甲氧基苯甲酸(13)、丁香酸(14)、3-hydroxy-4-methoxy-benzene carboxylic acid(15)、香草酸(16)、丁香酸甲酯(17)、4-羟基-3-甲氧基苯丙酮(18)、去甲丁香色原酮(19...

关 键 词:麻黄属  中麻黄  抗哮喘活性  3-羟基-5-(4’-羟基苯基)戊酸乙酯  3-羟基-5-(4’-羟基苯基)戊酸甲酯  4-羟基-3-甲氧基苯丙酮
收稿时间:2023-12-25

Two new natural products of Ephedra intermedia
FAN Xiling,CAO Yangang,JIAO Xinmian,MA Xinyi,ZHENG Xiaoke,FENG Weisheng. Two new natural products of Ephedra intermedia[J]. Chinese Traditional and Herbal Drugs, 2024, 55(6): 1899-1907
Authors:FAN Xiling  CAO Yangang  JIAO Xinmian  MA Xinyi  ZHENG Xiaoke  FENG Weisheng
Affiliation:School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China;Henan Engineering Technology Research Center for Chinese Medicine Development, Zhengzhou 450046, China
Abstract: Objective To investigate chemical constituents of Ephedra intermedia. Methods The monomer compounds of this plant were isolated by various chromatographic techniques such as Toyopreal HW-40C, Sephadex LH-20, silica gel and semi-preparative HPLC. And their structures were determined by analysis of physicochemical properties and spectral data. The anti-asthma activities of these compounds from E. intermedia were evaluated by establishing an in vitro model of RBL-2H3 cells degranulation induced by C48/80. Results A total of 21 compounds were isolated from 50% acetone extract of E. intermedia, and identified as 3-hydroxy-5-(4''-hydroxyphenyl) ethyl valerate (1), 3-hydroxy-5-(4''-hydroxyphenyl) methyl valerate (2), catechol (3), benzoic acid (4), 5-(4-hydroxyphenyl)-2-pentenoic acid (5), (+)-rhododendrol (6), frambinone (7), acetovanillone (8), methyl-4-hydroxy-3-methoxybenzoate (9), 3,4-dihydroxyphenylethanol (10), zingerone (11), protocatechuate (12), 3,5-dihydroxy-4-methoxy-benzoic acid (13), syringic acid (14), 3-hydroxy-4-methoxy-benzene carboxylic acid (15), vanillic acid (16), methyl syringate (17), 4-hydroxy-3-methoxypropiophenone (18), noreugenin (19), 5-(3,4-dihydroxyphenyl)-γ-valerolactone (20), 2-guaiacylpropane-1,3-diol (21). The results of their anti-asthma activities showed that compounds 5, 18, 19 (P < 0.05, 0.01) could significantly inhibit the release of β-hexosaminidase (β-Hex) at the concentration of 10 μmol/L, and compounds 4, 6, 8, 11, 20, 21 could slightly inhibit the release of β-Hex at the concentration of 10 μmol/L. Conclusion Compounds 1 and 2 are two new natural products determined their absolute configurations for the first time, and compounds 3, 515, and 1721 were isolated from E. intermedia for the first time. The results of in vitro anti-asthma activities screening showed that compounds 5, 18, 19 could significantly improve RBL-2H3 degranulation, and compounds 4, 6, 8, 11, 20, 21 could slightly improve RBL-2H3 degranulation at the concentration of 10 μmol/L.
Keywords:Ephedra L.  Ephedrae intermedia Schrenk ex C. A. Mey.  anti-asthma activity  3-hydroxy-5-(4''-hydroxyphenyl) ethyl valerate  3-hydroxy-5-(4''-hydroxyphenyl) methyl valerate  4-hydroxy-3-methoxypropiophenone
点击此处可从《中草药》浏览原始摘要信息
点击此处可从《中草药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号